"Psychosis" is an umbrella term used in the description of various conditions that involve delusions and hallucinations. This article will focus on the management of schizophrenia. Schizophrenia is a complex disorder, which provides many pharmacotherapy-related challenges. Advances have been made in the treatment of the condition. However, this requires a team approach, with the pharmacist monitoring treatment, both for safety and efficacy. The involvement of medicines that might possibly modulate the N-methyl-D-aspartate receptors is an exciting development that should be monitored. © Medpharm.
|Number of pages
|SA Pharmaceutical Journal
|Published - 1 Jan 2014
- Antipsychotic drugs
- First-generation antipsychotic drugs
- Second-generation antipsychotic drugs